The Department of Pathology, Microbiology and Immunology provides a unique and critical link between the basic and clinical sciences.
The combined approaches of prevention and cure give the researchers-and cat lovers-great hopes of saving felines from FIP once and for all.
The antiviral team, which includes board-certified veterinarians with special interests in infectious diseases, pathology, and virology, has launched two clinical trials described in the “Clinical Updates” section of this issue of Synergy. Pesavento leads the team of biophysicists, immunologists, and vaccinologists who are applying technologies used to study another coronavirus disease: COVID-19. We are tackling this decades-old problem by assembling teams that are developing antiviral therapy to cure the disease, and studies on potential prevention,” says Professor Patricia Pesavento, chair of the Pathology, Microbiology and Immunology department- a centerpoint for collaborators across the school. “It is heartbreaking when feline coronavirus mutates into the often-fatal FIP virus, most commonly in young cats or kittens.
